MXCT
Maxcyte·NASDAQ
--
--(--)
--
--(--)
MXCT fundamentals
Maxcyte (MXCT) Revenue Breakdown: Q3 2025 Business & Regional Performance
Maxcyte (MXCT) reported total revenue of 6.83M USD in Q3 2025, with its core business segment Product Sales contributing 57.89%. Regionally, Inside The United States remained the largest market, accounting for 56.17% of total revenue. Explore Maxcyte's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Maxcyte (MXCT) reported total revenue of 6.83M USD in Q3 2025, with its core business segment Product Sales contributing 57.89%. Regionally, Inside The United States remained the largest market, accounting for 56.17% of total revenue. Explore Maxcyte's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What guidance did Maxcyte's management provide for the next earnings period?What is the market's earnings forecast for Maxcyte next quarter?What is the revenue and EPS growth rate for Maxcyte year over year?What were the key takeaways from Maxcyte's earnings call?What were the key takeaways from Maxcyte’s earnings call?What is Maxcyte's latest dividend and current dividend yield?What is Maxcyte's gross profit margin?What factors drove the changes in Maxcyte's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
